| 货号 | 中文品名 | CAS No. | 别名 |
| WT-DM-C22255 | ITSA1 | 200626-61-5 | |
| WT-DM-C22256 | Resminostat (hydrochloride) | 1187075-34-8 | 4SC-201 |
| WT-DM-C22258 | Pim-1 Inhibitor 2 | 477845-12-8 | PIMi II |
| WT-DM-C22259 | Nitecapone | 116313-94-1 | OR-462 |
| WT-DM-C22260 | (S)-Ibuprofen | 51146-56-6 | Dexibuprofen |
| WT-DM-C22262 | Altiratinib | 1345847-93-9 | |
| WT-DM-C22265 | MKT-077 | 147366-41-4 | FJ-776 |
| WT-DM-C22266 | Darapladib | 356057-34-6 | SB-480848 |
| WT-DM-C22267 | Chlorothiazide | 58-94-6 | Diuril |
| WT-DM-C22270 | 3-(4-Pyridyl)indole | 7272-84-6 | Rho Kinase Inhibitor III |
| WT-DM-C22271 | PR-619 | 2645-32-1 | 2,6-Diamino-3,5-dithiocyanopyridine |
| WT-DM-C22273 | Nitisinone | 104206-65-7 | NTBC |
| WT-DM-C22275 | Danusertib | 827318-97-8 | PHA-739358 |
| WT-DM-C22276 | Pranoprofen | 52549-17-4 | Pyranoprofen |
| WT-DM-C22277 | LGK974 | 1243244-14-5 | PORCN Inhibitor IV |
| WT-DM-C22279 | MS37452 | 423748-02-1 | |
| WT-DM-C22280 | Baricitinib | 1187594-09-7 | INCB 028050 |
| WT-DM-C22283 | AEE788 | 497839-62-0 | NVP-AEE788 |
| WT-DM-C22284 | Spautin-1 | 1262888-28-7 | |
| WT-DM-C22285 | ZM 39923 (hydrochloride) | 1021868-92-7 | JAK3 Inhibitor IV |
| WT-DM-C22286 | Ibufenac | 1553-60-2 | Dytransin |
| WT-DM-C22288 | Amastatin (hydrochloride) | 100938-10-1 | |
| WT-DM-C22289 | FG-2216 | 223387-75-5 | IOX3 |
| WT-DM-C22290 | 2-Acetamidophenyl 5-chloro-2-nitrophenyl sulfide | 107522-19-0 | 2'-(5-chloro-2-nitrophenylthio)-Acetanilide |
| WT-DM-C22291 | AY 9944 | 366-93-8 | |
| WT-DM-C22293 | Bikinin | 188011-69-0 | |
| WT-DM-C22295 | CGI1746 | 910232-84-7 | |
| WT-DM-C22296 | Eeyarestatin 1 | 412960-54-4 | |
| WT-DM-C22297 | (R)-Lansoprazole | 138530-94-6 | (+)-Lansoprazole |
| WT-DM-C22298 | Sulindac sulfide | 49627-27-2 | |
| WT-DM-C22299 | Mutant IDH1-IN-1 | 1355326-21-4 | |
| WT-DM-C22302 | RI-2 | 1417162-36-7 | |
| WT-DM-C22303 | Sivelestat (sodium salt hydrate) | 201677-61-4 | LY544349 |
| WT-DM-C22304 | BYL719 | 1217486-61-7 | Alpelisib |
| WT-DM-C22305 | Neratinib | 698387-09-6 | HKI-272 |
| WT-DM-C22306 | Tolmetin (sodium salt hydrate) | 64490-92-2 | |
| WT-DM-C22310 | Binimetinib | 606143-89-9 | ARRY-438162 |
| WT-DM-C22311 | SGX523 | 1022150-57-7 | |
| WT-DM-C22315 | LHW090-A7 | C20H21ClNO4 ? Na | |
| WT-DM-C22317 | UCN-01 | 112953-11-4 | NSC 638850 |
| WT-DM-C22318 | L189 | 64232-83-3 | |
| WT-DM-C22319 | Refametinib | 923032-37-5 | BAY 86-9766 |
| WT-DM-C22320 | BAM15 | 210302-17-3 | |
| WT-DM-C22321 | Vidofludimus | 717824-30-1 | 4SC-101 |
| WT-DM-C22322 | Dabrafenib | 1195765-45-7 | GSK2118436 |
| WT-DM-C22323 | Aurora Kinase Inhibitor II | 331770-21-9 | 4-(4?-Benzamidoanilino)-6,7-dimethoxyquinazoline |
| WT-DM-C22324 | P32/98 (hemifumarate) | 251572-86-8 | |
| WT-DM-C22325 | 4E1RCat | 328998-25-0 | eIF4E/eIF4G Interaction Inhibitor II |
| WT-DM-C22326 | SNS-032 | 345627-80-7 | BMS-387032 |
| WT-DM-C22330 | Ezatiostat | 168682-53-9 | Terrapin 199 |
| WT-DM-C22333 | MJ33 (lithium salt) | 1007476-63-2 | |
| WT-DM-C22334 | Eggmanone | 505068-32-6 | |
| WT-DM-C22337 | Clorgyline (hydrochloride) | 17780-75-5 | N-2,4-Dichlorophenoxypropyl-N-methylpropargylamine |
| WT-DM-C22338 | ZM 306416 | 690206-97-4 | CB-676475 |
| WT-DM-C22340 | FTase Inhibitor II (trifluoroacetate salt) | | |
| WT-DM-C22341 | Edrophonium (chloride) | 116-38-1 | |
| WT-DM-C22342 | UNC0379 | 1620401-82-2 | |
| WT-DM-C22343 | WWL123 | 1338574-83-6 | |
| WT-DM-C22344 | (S)-MG115 | 133407-86-0 | |
| WT-DM-C22346 | IPI-145 | 1201438-56-3 | Duvelisib |
| WT-DM-C22347 | UNC0646 | 1320288-17-2 | |
| WT-DM-C22348 | BG45 | 926259-99-6 | |
| WT-DM-C22349 | XY1 | 1624117-53-8 | |
| WT-DM-C22350 | Tubastatin A | 1252003-15-8 | |
| WT-DM-C22353 | UNC0631 | 1320288-19-4 | |
| WT-DM-C22354 | UNC2025 | 1429881-91-3 | |
| WT-DM-C22356 | SecinH3 | 853625-60-2 | |
| WT-DM-C22357 | RGFP966 | 1357389-11-7 | |
| WT-DM-C22360 | Pexidartinib | 1029044-16-3 | PLX3397 |
| WT-DM-C22361 | Rofecoxib | 162011-90-7 | MK-966 |
| WT-DM-C22363 | U-104 | 178606-66-1 | NSC 213841 |
| WT-DM-C22364 | Conoidin A | 18080-67-6 | |
| WT-DM-C22365 | Kobe 0065 | 436133-68-5 | |
| WT-DM-C22366 | IKK-16 (hydrochloride) | 1186195-62-9 | IKK Inhibitor VII |
| WT-DM-C22367 | ALK5 Inhibitor II (hydrochloride) | 2319939-07-4 | E 616452 |
| WT-DM-C22368 | RKI-1447 | 1342278-01-6 | |
| WT-DM-C22373 | Calphostin C | 121263-19-2 | Cladochrome E |
| WT-DM-C22374 | DL-α-Difluoromethylornithine (hydrochloride hydrate) | 96020-91-6 | DFMO |
| WT-DM-C22377 | Actinonin | 13434-13-4 | (-)-Actinonin |
| WT-DM-C22379 | Conduritol B epoxide | 6090-95-5 | CBE |
| WT-DM-C22380 | Brassinazole | 224047-41-0 | |
| WT-DM-C22382 | WZ4002 | 1213269-23-8 | |
| WT-DM-C22383 | Aminoethoxyvinyl Glycine (hydrochloride) | 55720-26-8 | ABG 3168 |
| WT-DM-C22384 | R547 | 741713-40-6 | Ro 4584820 |
| WT-DM-C22386 | Rucaparib | 283173-50-2 | AG-014447 |
| WT-DM-C22387 | Kobe 2602 | 454453-49-7 | |
| WT-DM-C22388 | LRRK2-IN-1 | 1234480-84-2 | Leucine-rich repeat kinase 2 IN-1 |
| WT-DM-C22389 | Roquefortine C | 58735-64-1 | NSC 292134 |
| WT-DM-C22391 | b-AP15 | 1009817-63-3 | |
| WT-DM-C22392 | Lometrexol (hydrate) | | |
| WT-DM-C22393 | CX-4945 | 1009820-21-6 | Silmitasertib |
| WT-DM-C22394 | SF1670 | 345630-40-2 | |
| WT-DM-C22395 | MAZ51 | 163655-37-6 | |
| WT-DM-C22398 | LEI-106 | 1620582-23-1 | |
| WT-DM-C22399 | CRT0066101 (hydrochloride) | 1781742-22-0 | |
| WT-DM-C22401 | HPOB | 1429651-50-2 | |
| WT-DM-C22404 | CO-1686 | 1374640-70-6 | AVL-301 |
| WT-DM-C22405 | Avasimibe | 166518-60-1 | Cl-1011 |
| WT-DM-C22406 | R406 | 841290-80-0 | |
| WT-DM-C22407 | ONX 0912 | 935888-69-0 | Oprozomib |
| WT-DM-C22409 | BCATc Inhibitor 2 | 406191-34-2 | Cytosolic Branched-Chain Amino Acid Transferase Inhibitor 2 |
| WT-DM-C22412 | TDZD-8 | 327036-89-5 | GSK3β Inhibitor I |
| WT-DM-C22413 | Oxaprozin | 21256-18-8 | NSC 310839 |
| WT-DM-C22414 | (S)-PFI-2 (hydrochloride) | 1627607-88-8 | (+)-PFI-2 |
| WT-DM-C22416 | OTSSP167 (hydrochloride) | 1431698-10-0 | |
| WT-DM-C22417 | PFI-4 | 900305-37-5 | |
| WT-DM-C22419 | ONX 0914 | 960374-59-8 | PR-957 |
| WT-DM-C22420 | VX-745 | 209410-46-8 | Neflamapimod |
| WT-DM-C22421 | AT-9283 | 896466-04-9 | |
| WT-DM-C22422 | WIKI4 | 838818-26-1 | Tankyrase 1/2 Inhibitor V |
| WT-DM-C22423 | SP-141 | 1253491-42-7 | AGN-PC-0D106I |
| WT-DM-C22424 | AT7519 (hydrochloride) | 902135-91-5 | |
| WT-DM-C22427 | Sulindac sulfone | 59864-04-9 | Exisulind |
| WT-DM-C22429 | 2-Thenoyltrifluoroacetone | 326-91-0 | NSC 66544 |
| WT-DM-C22432 | kb NB 142-70 | 1233533-04-4 | |
| WT-DM-C22434 | Batimastat | 130370-60-4 | BB-94 |
| WT-DM-C22437 | AF3485 | 1195786-61-8 | CAY10686 |
| WT-DM-C22438 | XL147 | 934526-89-3 | Pilaralisib |
| WT-DM-C22439 | Cyclosporin A | | |
| WT-DM-C22440 | BIBR 1532 | 321674-73-1 | Telomerase Inhibitor X |
| WT-DM-C22441 | Ispinesib | 336113-53-2 | SB-715992 |
| WT-DM-C22442 | Sotrastaurin | 425637-18-9 | AEB071 |
| WT-DM-C22444 | SCR7 | 1533426-72-0 | |
| WT-DM-C22446 | Tadalafil | 171596-29-5 | |
| WT-DM-C22447 | Ki8751 | 228559-41-9 | |
| WT-DM-C22449 | Apixaban | 503612-47-3 | BMS 562247-01 |
| WT-DM-C22452 | IC-87114 | 371242-69-2 | |
| WT-DM-C22453 | AVL-292 | 1202757-89-8 | CC-292 |
| WT-DM-C22456 | Balicatib | 354813-19-7 | AAE581 |
| WT-DM-C22457 | XL019 | 945755-56-6 | |
| WT-DM-C22458 | JSH-23 | 749886-87-1 | NF-κB Activation Inhibitor II |
| WT-DM-C22460 | CX-6258 | 1202916-90-2 | Pim-Kinase Inhibitor X |
| WT-DM-C22461 | MLS-573151 | 10179-57-4 | |
| WT-DM-C22462 | PTC-209 | 315704-66-6 | |
| WT-DM-C22463 | BS-181 (hydrochloride) | 1397219-81-6 | |
| WT-DM-C22465 | Dinaciclib | 779353-01-4 | SCH 727965 |
| WT-DM-C22466 | Pazopanib | 444731-52-6 | GSK-VEG10003 |
| WT-DM-C22468 | Epalrestat | 82159-09-9 | ONO-2235 |
| WT-DM-C22469 | MCC950 | 210826-40-7 | CP 456,773 |
| WT-DM-C22470 | D-Mannoheptulose | 3615-44-9 | NSC 226836 |
| WT-DM-C22472 | VEGFR2 Kinase Inhibitor I | 15966-93-5 | SU 5408 |
| WT-DM-C22474 | 4EGI-1 | 315706-13-9 | eIF4E/eIF4G Interaction Inhibitor |
| WT-DM-C22475 | SD 208 | 627536-09-8 | TGF-β RI Kinase Inhibitor V |
| WT-DM-C22476 | Tandutinib | 387867-13-2 | CT 53518 |
| WT-DM-C22477 | (R)-PFI-2 (hydrochloride) | 1627607-87-7 | (-)-PFI-2 |
| WT-DM-C22478 | MJN110 | 1438416-21-7 | 2,5-Dioxopyrrolidin-1-yl 4-[bis(4-chlorophenyl)methyl]piperazine-1-carboxylate |
| WT-DM-C22480 | Autocamtide-2-related Inhibitory Peptide | C64H116N22O19 ? CF3COOH | |
| WT-DM-C22481 | Vardenafil (hydrochloride hydrate) | 330808-88-3 | |
| WT-DM-C22482 | TIQ-A | 420849-22-5 | |
| WT-DM-C22483 | P11 | 942285-55-4 | |
| WT-DM-C22484 | VU0359595 | | |
| WT-DM-C22486 | STF-118804 | 894187-61-2 | |
| WT-DM-C22488 | RHC-80267 | 83654-05-1 | U-57908 |
| WT-DM-C22489 | Enalaprilat (hydrate) | 84680-54-6 | |
| WT-DM-C22490 | 2-hexyl-4-Pentynoic Acid | 96017-59-3 | |
| WT-DM-C22497 | Gimeracil | 103766-25-2 | CDHP |
| WT-DM-C22498 | VEGFR2 Kinase Inhibitor II | 288144-20-7 | |
| WT-DM-C22502 | KD 025 | 911417-87-3 | Belumosudil |
| WT-DM-C22503 | Wnt-C59 | 1243243-89-1 | PORCN Inhibitor II |
| WT-DM-C22504 | Dovitinib | 405169-16-6 | CHIR258 |
| WT-DM-C22507 | 2-Phenyl-2-(1-piperidinyl)propane | 92321-29-4 | 1-(α,α-dimethylbenzyl)-Piperidine |
| WT-DM-C22508 | Q-VD-OPH | 1135695-98-5 | Quinoline-Val-Asp-Difluorophenoxymethyl Ketone |
| WT-DM-C22509 | LB 42708 | 226929-39-1 | |
| WT-DM-C22510 | MN-64 | 92831-11-3 | |
| WT-DM-C22512 | YZ9 | 6093-71-6 | 7-hydroxycoumarin-3-Carboxylic Acid ethyl ester |
| WT-DM-C22513 | UNC2170 (maleate) | 2173992-60-2 | |
| WT-DM-C22514 | WP1130 | 856243-80-6 | Degrasyn |
